- Alopecia Areata
- Androgenic Alopecia
- Traction Alopecia
- Others
Alopecia Treatment Market size was valued at USD 8.6 Billion in 2022 and is anticipated to reach USD 21.4 Billion by 2029, growing at an 11.2% CAGR from 2023 to 2029. Alopecia is an autoimmune disorder in which hair loss and baldness have been observed in both males and females. Various drugs and treatments are marketed such as hair transplant, scalp reduction, and others that prevent alopecia, the incidence of alopecia has increased by 49.2% globally which is higher in the 20-24- and 30-34-years age group for males and females. The change in lifestyle along with rising stress levels and unbalanced diets are the major cause of hair fall which influence the alopecia treatment market demand. In addition, the increasing geriatric population and hormonal changes cause alopecia which drives the alopecia treatment market growth. The market for alopecia treatment is filled with local and international key players, increase in research and development activities accelerate the market, increasing prevalence of Type 1 diabetes, thyroid illness, and multiple sclerosis linked with genetic disorder cause hair fall issues which creates numerous opportunities in alopecia treatment market. The cost of treatment involves high medications and artificial hair transplants are expensive, also strict regulations policies regarding medications and lack of awareness among people restrain the market growth. Geographically, North America held the major alopecia treatment market share in 2022 and is expected to dominate the global alopecia treatment market report due to the increasing prevalence of auto-immune disorder in the region.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The increasing prevalence of autoimmune disorders across the world is the major market driver in the Alopecia Treatment Market during the forecast period. The autoimmune disorder is caused due to unhealthy diet and improper lifestyle, 60% of the population suffers from thin hair, with pattern hair loss in both males and females which demands effective treatment options to prevent alopecia. In addition, increasing spending on healthcare infrastructure accelerates the development of treatment options and raises awareness about hair regrowth and treatment alternatives. The genetic factor is directly involved in hair fall, the person suffers from type 1 diabetes, and hypertension is linked with the patient or family. Hence, this will drive the global market growth at a significant rate.
The alopecia treatment market size was valued at usd 8.6 billion in 2022 and is anticipated to reach usd 21.4 billion by 2029
The alopecia treatment market is poised to grow at a significant cagr of 11.2% from 2023 to 2029.
The leading players in the alopecia treatment market are Johnson & Johnson Services, Inc., Merck & Co. Inc., Cipla Limited, Sun Pharmaceuticals Industries Ltd., Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc., Aurobindo Pharma, and Mylan N.V. (Viatris Inc.)
Historic years considered for the market study are 2018 through 2022, 2022 is considered as the base year for market estimation, and Seven years forecast is presented from 2023 – 2029.
1.Executive Summary |
2.Global Alopecia Treatment Market Introduction |
2.1.Global Alopecia Treatment Market - Taxonomy |
2.2.Global Alopecia Treatment Market - Definitions |
2.2.1.Cell Type |
2.2.2.Drug Class |
2.2.3.End User |
2.2.4.Region |
3.Global Alopecia Treatment Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Alopecia Treatment Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Alopecia Treatment Market By Cell Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Alopecia Areata |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Androgenic Alopecia |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Traction Alopecia |
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Others |
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6.Global Alopecia Treatment Market By Drug Class, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. Corticosteroids |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. 5AR Inhibitors |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Vasodilators |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Others |
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7.Global Alopecia Treatment Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. Retail Pharmacy |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Hospital Pharmacy |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Online Pharmacy |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global Alopecia Treatment Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Alopecia Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. Cell Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Alopecia Areata |
9.1.2.Androgenic Alopecia |
9.1.3.Traction Alopecia |
9.1.4.Others |
9.2. Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Corticosteroids |
9.2.2.5AR Inhibitors |
9.2.3.Vasodilators |
9.2.4.Others |
9.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Retail Pharmacy |
9.3.2.Hospital Pharmacy |
9.3.3.Online Pharmacy |
9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Alopecia Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Cell Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Alopecia Areata |
10.1.2.Androgenic Alopecia |
10.1.3.Traction Alopecia |
10.1.4.Others |
10.2. Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Corticosteroids |
10.2.2.5AR Inhibitors |
10.2.3.Vasodilators |
10.2.4.Others |
10.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Retail Pharmacy |
10.3.2.Hospital Pharmacy |
10.3.3.Online Pharmacy |
10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
10.4.7. |
11.Asia Pacific (APAC) Alopecia Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Cell Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Alopecia Areata |
11.1.2.Androgenic Alopecia |
11.1.3.Traction Alopecia |
11.1.4.Others |
11.2. Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Corticosteroids |
11.2.2.5AR Inhibitors |
11.2.3.Vasodilators |
11.2.4.Others |
11.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Retail Pharmacy |
11.3.2.Hospital Pharmacy |
11.3.3.Online Pharmacy |
11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Alopecia Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Cell Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Alopecia Areata |
12.1.2.Androgenic Alopecia |
12.1.3.Traction Alopecia |
12.1.4.Others |
12.2. Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Corticosteroids |
12.2.2.5AR Inhibitors |
12.2.3.Vasodilators |
12.2.4.Others |
12.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Retail Pharmacy |
12.3.2.Hospital Pharmacy |
12.3.3.Online Pharmacy |
12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Alopecia Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
13.1. Cell Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Alopecia Areata |
13.1.2.Androgenic Alopecia |
13.1.3.Traction Alopecia |
13.1.4.Others |
13.2. Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Corticosteroids |
13.2.2.5AR Inhibitors |
13.2.3.Vasodilators |
13.2.4.Others |
13.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Retail Pharmacy |
13.3.2.Hospital Pharmacy |
13.3.3.Online Pharmacy |
13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Cellmid Ltd. (Australia) |
14.2.2.Cipla Ltd. (India) |
14.2.3.Reddys Laboratories Ltd. (India) |
14.2.4.Johnson & Johnson Services, Inc. (U.S) |
14.2.5.Merck & Co., Inc. (U.S) |
14.2.6.Phyto Ales Group (France) |
14.2.7.Shiseido Co., Ltd.(Japan) |
14.2.8.Sun Pharmaceutical Industries Ltd. (India) |
15. Research Methodology |
16. Appendix and Abbreviations |